Literature DB >> 12144219

Systemic inflammatory response syndrome.

C A Botwinski1.   

Abstract

Despite advances in perinatal care in the past decade, sepsis and its complications continue to present problems for the neonate, remaining a major cause of neonatal morbidity and mortality. Sepsis research is focusing on how the neonate (host) responds to bacteria. The newborn may develop a systemic reaction to bacteria that induces the release of substances known as inflammatory mediators. Termed the systemic inflammatory response syndrome (SIRS), this reaction is believed to be responsible for the signs and symptoms of sepsis. This article introduces the neonatal nurse to SIRS, providing an overview of various inflammatory mediators and cytokines, their clinical consequences, and potential new therapies in the management of SIRS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12144219     DOI: 10.1891/0730-0832.20.5.21

Source DB:  PubMed          Journal:  Neonatal Netw        ISSN: 0730-0832


  2 in total

1.  Protection by mTOR Inhibition on Zymosan-Induced Systemic Inflammatory Response and Oxidative/Nitrosative Stress: Contribution of mTOR/MEK1/ERK1/2/IKKβ/IκB-α/NF-κB Signalling Pathway.

Authors:  Seyhan Sahan-Firat; Meryem Temiz-Resitoglu; Demet Sinem Guden; Sefika Pinar Kucukkavruk; Bahar Tunctan; Ayse Nihal Sari; Zumrut Kocak; Kafait U Malik
Journal:  Inflammation       Date:  2018-02       Impact factor: 4.092

2.  Ketamine inhibits TNF-α-induced cecal damage by enhancing RIP1 ubiquitination to attenuate lethal SIRS.

Authors:  Bin Deng; Daowei Yang; Huanghui Wu; Lu Wang; Rui Wu; Hongrui Zhu; Ailing Huang; Jingyi Song; Tieliang Cai; Shanshan Liu; Jingsi Wu; Huiying Zhou; Chunhui Li
Journal:  Cell Death Discov       Date:  2022-02-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.